- Home
- GSAT vs ICUI Comparison
GSAT vs ICUI Comparison
Compare GSAT & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSAT
- ICUI
- Stock Information
- Founded
- GSAT 2003
- ICUI 1984
- Country
- GSAT United States
- ICUI United States
- Employees
- GSAT N/A
- ICUI N/A
- Industry
- GSAT Telecommunications Equipment
- ICUI Medical/Dental Instruments
- Sector
- GSAT Consumer Discretionary
- ICUI Health Care
- Exchange
- GSAT Nasdaq
- ICUI Nasdaq
- Market Cap
- GSAT 3.4B
- ICUI 3.8B
- IPO Year
- GSAT 2006
- ICUI 1992
- Fundamental
- Price
- GSAT $1.88
- ICUI $163.87
- Analyst Decision
- GSAT Strong Buy
- ICUI Buy
- Analyst Count
- GSAT 1
- ICUI 4
- Target Price
- GSAT $5.00
- ICUI $199.67
- AVG Volume (30 Days)
- GSAT 14.0M
- ICUI 212.8K
- Earning Date
- GSAT 02-26-2025
- ICUI 02-25-2025
- Dividend Yield
- GSAT N/A
- ICUI N/A
- EPS Growth
- GSAT N/A
- ICUI N/A
- EPS
- GSAT N/A
- ICUI N/A
- Revenue
- GSAT $241,581,000.00
- ICUI $2,340,097,000.00
- Revenue This Year
- GSAT $13.67
- ICUI $4.38
- Revenue Next Year
- GSAT $8.07
- ICUI $0.34
- P/E Ratio
- GSAT N/A
- ICUI N/A
- Revenue Growth
- GSAT 13.58
- ICUI 4.04
- 52 Week Low
- GSAT $1.00
- ICUI $86.80
- 52 Week High
- GSAT $2.74
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- GSAT 45.19
- ICUI 54.19
- Support Level
- GSAT $1.82
- ICUI $151.92
- Resistance Level
- GSAT $1.93
- ICUI $168.50
- Average True Range (ATR)
- GSAT 0.14
- ICUI 5.21
- MACD
- GSAT -0.04
- ICUI 1.20
- Stochastic Oscillator
- GSAT 16.36
- ICUI 73.47
About GSAT Globalstar Inc.
Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services are typically used by customers where existing terrestrial wireline and wireless communications networks are impaired or do not exist. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is an owner of satellite assets. The company generates the vast majority of its revenue within the United States.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.